XWELL, Inc. (XWEL)
(Delayed Data from NSDQ)
$1.89 USD
-0.01 (-0.53%)
Updated Aug 13, 2024 03:23 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
XWEL 1.89 -0.01(-0.53%)
Will XWEL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for XWEL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for XWEL
Teladoc (TDOC) Reports Q3 Loss, Lags Revenue Estimates
Beyond Air, Inc. (XAIR) Reports Q1 Loss, Lags Revenue Estimates
XWEL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates
NovoCure (NVCR) Reports Q1 Loss, Lags Revenue Estimates
Co-Diagnostics, Inc. (CODX) Reports Q4 Loss, Misses Revenue Estimates
Other News for XWEL
XWELL Comments on CPC?s Withdrawal of Threatened Proxy Fight and Related Lawsuit
Xwell responds to CPC Pain & Wellness SPV`s decision
XWELL Announces Closing of $1.4 Million Registered Direct Offering Priced At Premium to Market
XWELL Capital Boost: New Share Deals and Investor Agreements
XWELL announces $1.4M registered direct offering